APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automated Biobanking Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Automated Biobanking Solution Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchAutomated Biobanking Solution Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Automated Biobanking Solution Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Automated Biobanking Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automated Biobanking Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Automated Biobanking Solution Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global Automated Biobanking Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Automated Biobanking Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Automated Biobanking Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Automated Biobanking Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Automated Biobanking Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Automated Biobanking Solution market include Thermo Fisher Scientific, Air Liquide, Brooks Automation, SPT Labtech, Modul-Bio, Azenta, LabVantage, OMNI Life Science and Calibre Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Automated Biobanking Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Automated Biobanking Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Automated Biobanking Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Automated Biobanking Solution market.

Automated Biobanking Solution Segment by Company

Thermo Fisher Scientific

Air Liquide

Brooks Automation

SPT Labtech

Modul-Bio

Azenta

LabVantage

OMNI Life Science

Calibre Scientific

IQVIA

XiltriX

Esco Lifesciences Group

Hangzhou Baocheng Biotechnology

Shanghai Origincell Biological Cryo Equipment

Anhui Zhongke Meiling Cryogenics

Shanghai H-VISIONS Technology

Qingdao Haier Biomedical

Qingdao AUCMA Biomedical

Qingdao Dashoo

Qingdao Hisense Medical

Automated Biobanking Solution Segment by Type

Sample Preparation Devices

Cryobiology Storage System

Cryobiology Storage Consumables

Environmental Monitoring System

Laboratory Information Management Systems (LIMS)

Automated Biobanking Solution Segment by Application

Universities

Hospitals

Clinical Research Laboratories

Others

Automated Biobanking Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Automated Biobanking Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Automated Biobanking Solution key companies, revenue, market share, and recent developments.

3. To split the Automated Biobanking Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Automated Biobanking Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Automated Biobanking Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Automated Biobanking Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automated Biobanking Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automated Biobanking Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automated Biobanking Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Automated Biobanking Solution industry.

Chapter 3: Detailed analysis of Automated Biobanking Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Automated Biobanking Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Automated Biobanking Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Automated Biobanking Solution Industry Trends Table 2. Automated Biobanking Solution Industry Drivers Table 3. Automated Biobanking Solution Industry Opportunities and Challenges Table 4. Automated Biobanking Solution Industry Restraints Table 5. Global Automated Biobanking Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Automated Biobanking Solution Revenue Share by Company (2021-2026) Table 7. Global Automated Biobanking Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Automated Biobanking Solution Key Company Manufacturing Base & Headquarters Table 9. Global Automated Biobanking Solution Company, Product Type & Application Table 10. Global Automated Biobanking Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Automated Biobanking Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sample Preparation Devices Table 15. Significant Companies of Cryobiology Storage System Table 16. Significant Companies of Cryobiology Storage Consumables Table 17. Significant Companies of Environmental Monitoring System Table 18. Significant Companies of Laboratory Information Management Systems (LIMS) Table 19. Global Automated Biobanking Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Automated Biobanking Solution Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Automated Biobanking Solution Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Automated Biobanking Solution Sales Value Share by Type (2021-2026) Table 23. Global Automated Biobanking Solution Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Universities Table 25. Significant Companies of Hospitals Table 26. Significant Companies of Clinical Research Laboratories Table 27. Significant Companies of Others Table 28. Global Automated Biobanking Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Automated Biobanking Solution Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Automated Biobanking Solution Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Automated Biobanking Solution Sales Value Share by Application (2021-2026) Table 32. Global Automated Biobanking Solution Sales Value Share by Application (2027-2032) Table 33. Global Automated Biobanking Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Automated Biobanking Solution Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Automated Biobanking Solution Sales Value Share by Region (2021-2026) Table 36. Global Automated Biobanking Solution Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Automated Biobanking Solution Sales Value Share by Region (2027-2032) Table 38. Global Automated Biobanking Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Automated Biobanking Solution Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Automated Biobanking Solution Sales Value Market Share by Country (2021-2026) Table 41. Global Automated Biobanking Solution Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Automated Biobanking Solution Sales Value Market Share by Country (2027-2032) Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Thermo Fisher Scientific Automated Biobanking Solution Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. Air Liquide Company Information Table 49. Air Liquide Business Overview Table 50. Air Liquide Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Air Liquide Automated Biobanking Solution Product Portfolio Table 52. Air Liquide Recent Development Table 53. Brooks Automation Company Information Table 54. Brooks Automation Business Overview Table 55. Brooks Automation Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Brooks Automation Automated Biobanking Solution Product Portfolio Table 57. Brooks Automation Recent Development Table 58. SPT Labtech Company Information Table 59. SPT Labtech Business Overview Table 60. SPT Labtech Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. SPT Labtech Automated Biobanking Solution Product Portfolio Table 62. SPT Labtech Recent Development Table 63. Modul-Bio Company Information Table 64. Modul-Bio Business Overview Table 65. Modul-Bio Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Modul-Bio Automated Biobanking Solution Product Portfolio Table 67. Modul-Bio Recent Development Table 68. Azenta Company Information Table 69. Azenta Business Overview Table 70. Azenta Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Azenta Automated Biobanking Solution Product Portfolio Table 72. Azenta Recent Development Table 73. LabVantage Company Information Table 74. LabVantage Business Overview Table 75. LabVantage Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. LabVantage Automated Biobanking Solution Product Portfolio Table 77. LabVantage Recent Development Table 78. OMNI Life Science Company Information Table 79. OMNI Life Science Business Overview Table 80. OMNI Life Science Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. OMNI Life Science Automated Biobanking Solution Product Portfolio Table 82. OMNI Life Science Recent Development Table 83. Calibre Scientific Company Information Table 84. Calibre Scientific Business Overview Table 85. Calibre Scientific Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Calibre Scientific Automated Biobanking Solution Product Portfolio Table 87. Calibre Scientific Recent Development Table 88. IQVIA Company Information Table 89. IQVIA Business Overview Table 90. IQVIA Automated Biobanking Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. IQVIA Automated Biobanking Solution Product Portfolio Table 92. IQVIA Recent Development Table 93. XiltriX Company Information Table 94. XiltriX Business Overview Table 95. XiltriX Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. XiltriX Automated Biobanking Solution Product Portfolio Table 97. XiltriX Recent Development Table 98. Esco Lifesciences Group Company Information Table 99. Esco Lifesciences Group Business Overview Table 100. Esco Lifesciences Group Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Esco Lifesciences Group Automated Biobanking Solution Product Portfolio Table 102. Esco Lifesciences Group Recent Development Table 103. Hangzhou Baocheng Biotechnology Company Information Table 104. Hangzhou Baocheng Biotechnology Business Overview Table 105. Hangzhou Baocheng Biotechnology Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Hangzhou Baocheng Biotechnology Automated Biobanking Solution Product Portfolio Table 107. Hangzhou Baocheng Biotechnology Recent Development Table 108. Shanghai Origincell Biological Cryo Equipment Company Information Table 109. Shanghai Origincell Biological Cryo Equipment Business Overview Table 110. Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Product Portfolio Table 112. Shanghai Origincell Biological Cryo Equipment Recent Development Table 113. Anhui Zhongke Meiling Cryogenics Company Information Table 114. Anhui Zhongke Meiling Cryogenics Business Overview Table 115. Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Product Portfolio Table 117. Anhui Zhongke Meiling Cryogenics Recent Development Table 118. Shanghai H-VISIONS Technology Company Information Table 119. Shanghai H-VISIONS Technology Business Overview Table 120. Shanghai H-VISIONS Technology Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Shanghai H-VISIONS Technology Automated Biobanking Solution Product Portfolio Table 122. Shanghai H-VISIONS Technology Recent Development Table 123. Qingdao Haier Biomedical Company Information Table 124. Qingdao Haier Biomedical Business Overview Table 125. Qingdao Haier Biomedical Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Qingdao Haier Biomedical Automated Biobanking Solution Product Portfolio Table 127. Qingdao Haier Biomedical Recent Development Table 128. Qingdao AUCMA Biomedical Company Information Table 129. Qingdao AUCMA Biomedical Business Overview Table 130. Qingdao AUCMA Biomedical Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Qingdao AUCMA Biomedical Automated Biobanking Solution Product Portfolio Table 132. Qingdao AUCMA Biomedical Recent Development Table 133. Qingdao Dashoo Company Information Table 134. Qingdao Dashoo Business Overview Table 135. Qingdao Dashoo Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Qingdao Dashoo Automated Biobanking Solution Product Portfolio Table 137. Qingdao Dashoo Recent Development Table 138. Qingdao Hisense Medical Company Information Table 139. Qingdao Hisense Medical Business Overview Table 140. Qingdao Hisense Medical Automated Biobanking Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Qingdao Hisense Medical Automated Biobanking Solution Product Portfolio Table 142. Qingdao Hisense Medical Recent Development Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Automated Biobanking Solution Product Image Figure 2. Global Automated Biobanking Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Automated Biobanking Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Automated Biobanking Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sample Preparation Devices Image Figure 8. Cryobiology Storage System Image Figure 9. Cryobiology Storage Consumables Image Figure 10. Environmental Monitoring System Image Figure 11. Laboratory Information Management Systems (LIMS) Image Figure 12. Global Automated Biobanking Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Automated Biobanking Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Automated Biobanking Solution Sales Value Share by Type (2021-2032) Figure 15. Universities Image Figure 16. Hospitals Image Figure 17. Clinical Research Laboratories Image Figure 18. Others Image Figure 19. Global Automated Biobanking Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Automated Biobanking Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Automated Biobanking Solution Sales Value Share by Application (2021-2032) Figure 22. Global Automated Biobanking Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Automated Biobanking Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Automated Biobanking Solution Sales Value (2021-2032) & (US$ Million) Figure 25. North America Automated Biobanking Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Automated Biobanking Solution Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Automated Biobanking Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Automated Biobanking Solution Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Automated Biobanking Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Automated Biobanking Solution Sales Value (2021-2032) & (US$ Million) Figure 31. South America Automated Biobanking Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Automated Biobanking Solution Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Automated Biobanking Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Automated Biobanking Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Sample Preparation Devices
  • Cryobiology Storage System
  • Cryobiology Storage Consumables
  • Environmental Monitoring System
  • Laboratory Information Management Systems (LIMS)
Applications
  • Universities
  • Hospitals
  • Clinical Research Laboratories
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Air Liquide
  • Brooks Automation
  • SPT Labtech
  • Modul-Bio
  • Azenta
  • LabVantage
  • OMNI Life Science
  • Calibre Scientific
  • IQVIA
  • XiltriX
  • Esco Lifesciences Group
  • Hangzhou Baocheng Biotechnology
  • Shanghai Origincell Biological Cryo Equipment
  • Anhui Zhongke Meiling Cryogenics
  • Shanghai H-VISIONS Technology
  • Qingdao Haier Biomedical
  • Qingdao AUCMA Biomedical
  • Qingdao Dashoo
  • Qingdao Hisense Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Automated Biobanking Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Automated Biobanking Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Automated Biobanking Solution Market Dynamics
  1. 2.1 Automated Biobanking Solution Industry Trends
  2. 2.2 Automated Biobanking Solution Industry Drivers
  3. 2.3 Automated Biobanking Solution Industry Opportunities and Challenges
  4. 2.4 Automated Biobanking Solution Industry Restraints
3 Automated Biobanking Solution Market by Company
  1. 3.1 Global Automated Biobanking Solution Company Revenue Ranking in 2025
  2. 3.2 Global Automated Biobanking Solution Revenue by Company (2021-2026)
  3. 3.3 Global Automated Biobanking Solution Company Ranking (2024-2026)
  4. 3.4 Global Automated Biobanking Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Automated Biobanking Solution Company Product Type and Application
  6. 3.6 Global Automated Biobanking Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Automated Biobanking Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Automated Biobanking Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Automated Biobanking Solution Market by Type
  1. 4.1 Automated Biobanking Solution Type Introduction
  2. 4.1.1 Sample Preparation Devices
  3. 4.1.2 Cryobiology Storage System
  4. 4.1.3 Cryobiology Storage Consumables
  5. 4.1.4 Environmental Monitoring System
  6. 4.1.5 Laboratory Information Management Systems (LIMS)
  7. 4.2 Global Automated Biobanking Solution Sales Value by Type
  8. 4.2.1 Global Automated Biobanking Solution Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Automated Biobanking Solution Sales Value by Type (2021-2032)
  10. 4.2.3 Global Automated Biobanking Solution Sales Value Share by Type (2021-2032)
5 Automated Biobanking Solution Market by Application
  1. 5.1 Automated Biobanking Solution Application Introduction
  2. 5.1.1 Universities
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinical Research Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Automated Biobanking Solution Sales Value by Application
  7. 5.2.1 Global Automated Biobanking Solution Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Automated Biobanking Solution Sales Value by Application (2021-2032)
  9. 5.2.3 Global Automated Biobanking Solution Sales Value Share by Application (2021-2032)
6 Automated Biobanking Solution Regional Value Analysis
  1. 6.1 Global Automated Biobanking Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Automated Biobanking Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Automated Biobanking Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Automated Biobanking Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Automated Biobanking Solution Sales Value (2021-2032)
  7. 6.3.2 North America Automated Biobanking Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Automated Biobanking Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Automated Biobanking Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Automated Biobanking Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Automated Biobanking Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Automated Biobanking Solution Sales Value (2021-2032)
  16. 6.6.2 South America Automated Biobanking Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Automated Biobanking Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Automated Biobanking Solution Sales Value Share by Country, 2025 VS 2032
7 Automated Biobanking Solution Country-level Value Analysis
  1. 7.1 Global Automated Biobanking Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Automated Biobanking Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Automated Biobanking Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Automated Biobanking Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Automated Biobanking Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Automated Biobanking Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Automated Biobanking Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Automated Biobanking Solution Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Air Liquide
  8. 8.2.1 Air Liquide Company Information
  9. 8.2.2 Air Liquide Business Overview
  10. 8.2.3 Air Liquide Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Air Liquide Automated Biobanking Solution Product Portfolio
  12. 8.2.5 Air Liquide Recent Developments
  13. 8.3 Brooks Automation
  14. 8.3.1 Brooks Automation Company Information
  15. 8.3.2 Brooks Automation Business Overview
  16. 8.3.3 Brooks Automation Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Brooks Automation Automated Biobanking Solution Product Portfolio
  18. 8.3.5 Brooks Automation Recent Developments
  19. 8.4 SPT Labtech
  20. 8.4.1 SPT Labtech Company Information
  21. 8.4.2 SPT Labtech Business Overview
  22. 8.4.3 SPT Labtech Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SPT Labtech Automated Biobanking Solution Product Portfolio
  24. 8.4.5 SPT Labtech Recent Developments
  25. 8.5 Modul-Bio
  26. 8.5.1 Modul-Bio Company Information
  27. 8.5.2 Modul-Bio Business Overview
  28. 8.5.3 Modul-Bio Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Modul-Bio Automated Biobanking Solution Product Portfolio
  30. 8.5.5 Modul-Bio Recent Developments
  31. 8.6 Azenta
  32. 8.6.1 Azenta Company Information
  33. 8.6.2 Azenta Business Overview
  34. 8.6.3 Azenta Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Azenta Automated Biobanking Solution Product Portfolio
  36. 8.6.5 Azenta Recent Developments
  37. 8.7 LabVantage
  38. 8.7.1 LabVantage Company Information
  39. 8.7.2 LabVantage Business Overview
  40. 8.7.3 LabVantage Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LabVantage Automated Biobanking Solution Product Portfolio
  42. 8.7.5 LabVantage Recent Developments
  43. 8.8 OMNI Life Science
  44. 8.8.1 OMNI Life Science Company Information
  45. 8.8.2 OMNI Life Science Business Overview
  46. 8.8.3 OMNI Life Science Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OMNI Life Science Automated Biobanking Solution Product Portfolio
  48. 8.8.5 OMNI Life Science Recent Developments
  49. 8.9 Calibre Scientific
  50. 8.9.1 Calibre Scientific Company Information
  51. 8.9.2 Calibre Scientific Business Overview
  52. 8.9.3 Calibre Scientific Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Calibre Scientific Automated Biobanking Solution Product Portfolio
  54. 8.9.5 Calibre Scientific Recent Developments
  55. 8.10 IQVIA
  56. 8.10.1 IQVIA Company Information
  57. 8.10.2 IQVIA Business Overview
  58. 8.10.3 IQVIA Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IQVIA Automated Biobanking Solution Product Portfolio
  60. 8.10.5 IQVIA Recent Developments
  61. 8.11 XiltriX
  62. 8.11.1 XiltriX Company Information
  63. 8.11.2 XiltriX Business Overview
  64. 8.11.3 XiltriX Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 XiltriX Automated Biobanking Solution Product Portfolio
  66. 8.11.5 XiltriX Recent Developments
  67. 8.12 Esco Lifesciences Group
  68. 8.12.1 Esco Lifesciences Group Company Information
  69. 8.12.2 Esco Lifesciences Group Business Overview
  70. 8.12.3 Esco Lifesciences Group Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Esco Lifesciences Group Automated Biobanking Solution Product Portfolio
  72. 8.12.5 Esco Lifesciences Group Recent Developments
  73. 8.13 Hangzhou Baocheng Biotechnology
  74. 8.13.1 Hangzhou Baocheng Biotechnology Company Information
  75. 8.13.2 Hangzhou Baocheng Biotechnology Business Overview
  76. 8.13.3 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Baocheng Biotechnology Automated Biobanking Solution Product Portfolio
  78. 8.13.5 Hangzhou Baocheng Biotechnology Recent Developments
  79. 8.14 Shanghai Origincell Biological Cryo Equipment
  80. 8.14.1 Shanghai Origincell Biological Cryo Equipment Company Information
  81. 8.14.2 Shanghai Origincell Biological Cryo Equipment Business Overview
  82. 8.14.3 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Origincell Biological Cryo Equipment Automated Biobanking Solution Product Portfolio
  84. 8.14.5 Shanghai Origincell Biological Cryo Equipment Recent Developments
  85. 8.15 Anhui Zhongke Meiling Cryogenics
  86. 8.15.1 Anhui Zhongke Meiling Cryogenics Company Information
  87. 8.15.2 Anhui Zhongke Meiling Cryogenics Business Overview
  88. 8.15.3 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Anhui Zhongke Meiling Cryogenics Automated Biobanking Solution Product Portfolio
  90. 8.15.5 Anhui Zhongke Meiling Cryogenics Recent Developments
  91. 8.16 Shanghai H-VISIONS Technology
  92. 8.16.1 Shanghai H-VISIONS Technology Company Information
  93. 8.16.2 Shanghai H-VISIONS Technology Business Overview
  94. 8.16.3 Shanghai H-VISIONS Technology Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Shanghai H-VISIONS Technology Automated Biobanking Solution Product Portfolio
  96. 8.16.5 Shanghai H-VISIONS Technology Recent Developments
  97. 8.17 Qingdao Haier Biomedical
  98. 8.17.1 Qingdao Haier Biomedical Company Information
  99. 8.17.2 Qingdao Haier Biomedical Business Overview
  100. 8.17.3 Qingdao Haier Biomedical Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Qingdao Haier Biomedical Automated Biobanking Solution Product Portfolio
  102. 8.17.5 Qingdao Haier Biomedical Recent Developments
  103. 8.18 Qingdao AUCMA Biomedical
  104. 8.18.1 Qingdao AUCMA Biomedical Company Information
  105. 8.18.2 Qingdao AUCMA Biomedical Business Overview
  106. 8.18.3 Qingdao AUCMA Biomedical Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Qingdao AUCMA Biomedical Automated Biobanking Solution Product Portfolio
  108. 8.18.5 Qingdao AUCMA Biomedical Recent Developments
  109. 8.19 Qingdao Dashoo
  110. 8.19.1 Qingdao Dashoo Company Information
  111. 8.19.2 Qingdao Dashoo Business Overview
  112. 8.19.3 Qingdao Dashoo Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Qingdao Dashoo Automated Biobanking Solution Product Portfolio
  114. 8.19.5 Qingdao Dashoo Recent Developments
  115. 8.20 Qingdao Hisense Medical
  116. 8.20.1 Qingdao Hisense Medical Company Information
  117. 8.20.2 Qingdao Hisense Medical Business Overview
  118. 8.20.3 Qingdao Hisense Medical Automated Biobanking Solution Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Qingdao Hisense Medical Automated Biobanking Solution Product Portfolio
  120. 8.20.5 Qingdao Hisense Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst